Facteurs cliniques et résultats du don d'ovocytes

Vernaeve V, V. Vernaeve, Reis Soares S, Sérgio Reis Soares, S Reis Soares, Budak E, E. Budak, J. Bellver, José Bellver, Bellver J, J. Remohi, José Remohı́, Remohi J, Pellicer A, António Pellicer, A Pellicer
Gynecologie, obstetrique & fertilite · 2007 · vol. 35(10) , pp. 1015–1023 · doi:10.1016/j.gyobfe.2007.06.016 · PMID:17905636 · W2072826014
review OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper investigated the clinical factors associated with egg donation and its outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This article aims at reviewing the literature in order to provide a summary of the actual knowledge about the clinical factors of the oocyte recipient (other than those affecting the morphology of the uterine cavity) influencing the outcome of oocyte donation cycles. Recipient age, from 45 years onwards, is clearly associated with a poorer outcome in oocyte donation cycles as well as the presence of a hydrosalpinx. The negative impact of smoking has recently been confirmed. The exact influence of a high body mass index is under examination but it is likely that it is associated with a lower ongoing pregnancy rate. Endometriosis does not have a negative impact when standard endometrial priming protocols are used in oocyte donation. During endometrial priming, serum estradiol levels and endometrial thickness, if >5 mm, does not influence negatively the outcome; however duration of estrogen treatment of more than 7 weeks is associated with a diminished pregnancy and implantation rate.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Oocyte Donation Body Mass Index Endometriosis Endometriosis Endometrium Endometrium Estradiol Estradiol Female Humans Oocyte Donation Pregnancy Pregnancy Outcome Smoking

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (63)

Cited by (2)

Source provenance

europepmc
last seen: 2026-08-08T06:08:32.324769+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:48.452140+00:00
License: CC0 · commercial use OK